Published on 23 September 2022
Description:
New PharmaTimes is focusing on new eras, perspectives and dimensions. Our cover story asks whether industry is really opening doors to women. We also analyse how healthcare, specific to women, is embarking on a brave new chapter. Meanwhile, as a new Prime Minister gets her feet under the table, we look at the widespread health inequalities across the country.
Categories:
PharmaTimesPreview:
27 articles from this collection:
Cover
2 - Communique Awards
3 - From the editor
This month PharmaTimes presents Alantra’s annual ranking of the fastest growing pharma companies in the UK, and again there is much cause for celebration. As the analysis shows, a relentless focus on innovation and a determination to solve problems hindering patient outcomes are key traits that have helped those at the top shine in a sector that saw average growth of 33% in 2020.
4-5 - Contents
6 - NEWS: Treatments
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on the potential reclassification of two progestogen-only, oral contraceptive pills containing desogestrel: Lovima 75mcg and Hana 75mcg film-coated tablets.
7 - NEWS: Research
8 - NEWS: Collaboration
9 - NEWS: Conditions
10-11 - COVER STORY: Won
12-13 - WOMEN'S HEALTH: Mind the gap
14-15 - STEM CELLS: History in the making
16-17 - EQUITY: Scale of the challenge
18-19 - CONDITIONS: Brainwave
20 - PATIENTS: Staying ahead of the game
21 - SUSTAINABILITY: Treatable blisters?
22-23 - DIGITAL: Seven up
24-25 - CLINICAL TRIALS: Quick thinking
26-27 - NHS: Right time, right place?
28 - GENE THERAPIES: Access all areas
29 - INTCROY
30-31 - NET ZERO : Net result
32-33 - INDUSTRY: One step beyond
34-35 - Your moves
36-37 - PATIENTS: The X Factor
38 - SAMEDAN
39 - PHARMATIMES
40 - PMPS
PharmaTimes
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.